Skip to main content
. 2022 Oct 5;160(1):209–219. doi: 10.1007/s11060-022-04138-w

Table 2.

Median survival table for the five most common malignant tumors in each age group by time period of diagnosis (NPCR survival data: data provided by CDC's National Program of Cancer Registries SEER*Database: NPCR survival analytic file, 2004–2017)

Age at diagnosis Histopathology 2004–2007 2008–2012 2013–2017
Cases Deaths Median survival months (95% CI) Cases Deaths Median survival months (95% CI) Cases Deaths Median survival months (95% CI)
0–14 Diffuse astrocytoma 615 124 ** (**–**) 686 127 ** (**–**) 641 96 ** (**–**)
Embryonal tumors 1618 740 ** (**–**) 1975 770 ** (**–**) 1950 470 ** (**–**)
Ependymal tumors 218 95 ** (143–**) 371 126 ** (117–**) 427 51 ** (**–**)
Germ cell tumors 273 48 ** (**–**) 389 54 ** (**–**) 429 29 ** (**–**)
Glioblastoma 247 208 13 (11–15) 385 319 14 (13–16) 395 253 13 (12–16)
15–39 Anaplastic astrocytoma 884 536 87 (77–102) 1222 568 100 (89–**) 1538 280 ** (**–**)
Diffuse astrocytoma 1724 787 ** (157–**) 2151 690 ** (**–**) 2048 183 ** (**–**)
Glioblastoma 1570 1314 23 (21–25) 1989 1584 24 (23–25) 2303 1076 25 (23–27)
Oligoastrocytic tumors 834 368 ** (159–**) 1101 339 ** (**–**) 526 72 ** (**–**)
Oligodendroglioma 1108 342 ** (**–**) 1271 189 ** (**–**) 1216 34 ** (**–**)
40–64 Anaplastic astrocytoma 1620 1358 19.5 (18–21) 2135 1690 21 (20–23) 2346 1164 23 (22–25)
Diffuse astrocytoma 2223 1591 38 (34–44) 2584 1681 38 (33–41) 2152 851 39 (36–46)
Glioblastoma 14,201 13,696 11 (11–12) 19,367 18,338 13 (13–13) 20,430 14,037 13 (13–14)
Lymphoma 1936 1377 30 (25–37) 2522 1466 47 (42–55) 2658 959 ** (**–**)
Oligodendroglioma 1349 590 ** (158–**) 1505 430 ** (**–**) 1447 141 ** (**–**)
65+ Anaplastic astrocytoma 906 889 4 (4–5) 1159 1121 5 (5–6) 1319 1039 7 (6–7)
Diffuse astrocytoma 1237 1187 5 (5–6) 1333 1244 6 (5–6) 1248 886 8 (7–9)
Glioblastoma 13,099 12,970 4 (4–4) 17,875 17,571 4 (4–4) 20,675 16,920 5 (5–5)
Lymphoma 2047 1861 7 (6–8) 2802 2263 8 (7–10) 3409 1887 13 (11–15)
Meningioma 571 439 42 (36–53) 526 334 51 (40–61) 584 227 46 (37–**)

** Median survival not reached